WeVote
Log In

Bill

Bill

SB 1427

RELATING TO MANUFACTURED HEMP PRODUCTS.

2026 Regular Session Introduced by Ron Kouchi

SB 1427 establishes state licensing and regulatory standards for Hawaii's manufactured hemp products industry to ensure consumer safety and market consistency.

Carried over to 2026 Regular Session.
#doh #definition #manufacturedhempproducts
0
WeVote Research Nonpartisan
Bill Summary · SB 1427

Legislative bill overview

SB 1427 addresses the regulation and licensing of manufactured hemp products in Hawaii. The bill establishes frameworks for how hemp-derived products are produced, labeled, and sold within the state. The specific provisions remain under review in committee as the bill was carried over to the 2026 session.

Why is this important

Hawaii's hemp industry has grown substantially, but manufactured products (edibles, extracts, beverages) lack clear state oversight, creating inconsistencies in quality, potency labeling, and consumer safety. This bill would standardize regulations similar to how other states manage hemp-derived cannabinoid products like Delta-8 and Delta-10 THC, which currently exist in legal gray areas.

Potential points of contention

  • Definitional scope: Whether "manufactured hemp products" includes all cannabinoid extracts or only specific compounds, affecting which businesses must comply
  • Testing and labeling requirements: Establishing mandatory potency testing, contaminant screening, and warning labels could increase producer costs and market prices
  • Licensing burden: New licensing requirements may advantage large producers over small farmers and local manufacturers, or conversely, may be seen as insufficient oversight

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.